Works matching IS 11707690 AND DT 2010 AND VI 28

Results: 157

Predicting Direct Costs of HIV Care During the First Year of Darunavir-Based Highly Active Antiretroviral Therapy Using CD4 Cell Counts: Evidence from POWER.

Published in:

PharmacoEconomics, 2010, v. 28, p. 169, doi. 10.2165/11587510-000000000-00000

By:

Hill, Andrew M.;
Gebo, Kelly;
Hemmett, Lindsay;
Löthgren, Mickael;
Allegri, Gabriele;
Smets, Erik

Publication type:

Article

Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK.

Published in:

PharmacoEconomics, 2010, v. 28, p. 147, doi. 10.2165/11587500-000000000-00000

By:

Moeremans, Karen;
Hemmett, Lindsay;
Hjelmgren, Jonas;
Allegri, Gabriele;
Smets, Erik

Publication type:

Article

Modelling the Budget Impact of Darunavir in the Treatment of Highly Treatment-Experienced, HIV-Infected Adults in France.

Published in:

PharmacoEconomics, 2010, v. 28, p. 183, doi. 10.2165/11587520-000000000-00000

By:

Colin, Xavier;
Lafuma, Antoine;
Costagliola, Dominique;
Smets, Erik;
Mauskopf, Josephine;
Guillon, Pascal

Publication type:

Article

US Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Treatment-Experienced, HIV-Infected Adults with Evidence of Protease Inhibitor Resistance Included in the TITAN Trial.

Published in:

PharmacoEconomics, 2010, v. 28, p. 129, doi. 10.2165/11587490-000000000-00000

By:

Brogan, Anita;
Mauskopf, Josephine;
Talbird, Sandra E.;
Smets, Erik

Publication type:

Article

Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Protease Inhibitor-Experienced, HIV-1-Infected Adults in Belgium, Italy, Sweden and the UK.

Published in:

PharmacoEconomics, 2010, v. 28, p. 107, doi. 10.2165/11587480-000000000-00000

By:

Moeremans, Karen;
Annemans, Lieven;
Löthgren, Mickael;
Allegri, Gabriele;
Wyffels, Veronique;
Hemmet, Lindsay;
Caekelbergh, Karin;
Smets, Erik

Publication type:

Article

Cost Effectiveness of Darunavir/Ritonavir in Highly Treatment-Experienced, HIV-1-Infected Adults in the USA.

Published in:

PharmacoEconomics, 2010, v. 28, p. 83, doi. 10.2165/11587470-000000000-00000

By:

Mauskopf, Josephine;
Brogan, Anita;
Martin, Silas;
Smets, Erik

Publication type:

Article

Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients: The POWER Experience.

Published in:

PharmacoEconomics, 2010, v. 28, p. 69, doi. 10.2165/11587460-000000000-00000

By:

Hill, Andrew M.;
Clotet, Bonaventura;
Johnson, Margaret;
Stoll, Matthias;
Bellos, Nicholas;
Smets, Erik

Publication type:

Article

The Cost of Managing HIV Infection in Highly Treatment-Experienced, HIV-Infected Adults in France.

Published in:

PharmacoEconomics, 2010, v. 28, p. 59, doi. 10.2165/11587450-000000000-00000

By:

Colin, Xavier;
Lafuma, Antoine;
Costagliola, Dominique;
Lang, Jean-Marie;
Guillon, Pascal

Publication type:

Article

Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden.

Published in:

PharmacoEconomics, 2010, v. 28, p. 49, doi. 10.2165/11587440-000000000-00000

By:

Ghatnekar, Ola;
Hjortsberg, Catharina;
Gisslén, Magnus;
Lindbäck, Stefan;
Löthgren, Mickael

Publication type:

Article

The Impact of Disease Stage on Direct Medical Costs of HIV Management: A Review of the International Literature.

Published in:

PharmacoEconomics, 2010, v. 28, p. 35, doi. 10.2165/11587430-000000000-00000

By:

Levy, Adrian;
Johnston, Karissa;
Annemans, Lieven;
Tramarin, Andrea;
Montaner, Julio

Publication type:

Article

Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era.

Published in:

PharmacoEconomics, 2010, v. 28, p. 17, doi. 10.2165/11587420-000000000-00000

By:

Boyd, Mark A.;
Hill, Andrew M.

Publication type:

Article

A Review of Economic Evaluations of Darunavir Boosted by Low-Dose Ritonavir in Treatment-Experienced Persons Living with HIV Infection.

Published in:

PharmacoEconomics, 2010, v. 28, p. 1, doi. 10.2165/11587410-000000000-00000

By:

Mauskopf, Josephine;
Annemans, Lieven;
Hill, Andrew M.;
Smets, Erik

Publication type:

Article

The cost utility of autologous chondrocytes implantation using ChondroCelect® in symptomatic knee cartilage lesions in Belgium.

Published in:

2010

By:

Gerlier L;
Lamotte M;
Wille M;
Kreuz PC;
Vanlauwe J;
Dubois D;
Meurgey FM;
Gerlier, Laetitia;
Lamotte, Mark;
Wille, Micheline;
Kreuz, Peter C;
Vanlauwe, Johan;
Dubois, Dominique;
Meurgey, François M

Publication type:

journal article

The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments.

Published in:

2010

By:

Manca A;
Sculpher MJ;
Goeree R;
Manca, Andrea;
Sculpher, Mark J;
Goeree, Ron

Publication type:

journal article

The Cost Utility of Autologous Chondrocytes Implantation Using ChondroCelect in Symptomatic Knee Cartilage Lesions in Belgium.

Published in:

PharmacoEconomics, 2010, v. 28, n. 12, p. 1129, doi. 10.2165/11584920-000000000-00000

By:

Gerlier, Laetitia;
Lamotte, Mark;
Wille, Micheline;
Kreuz, Peter C.;
Vanlauwe, Johan;
Dubois, Dominique;
Meurgey, François M.

Publication type:

Article

Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance.

Published in:

PharmacoEconomics, 2010, v. 28, n. 12, p. 1123, doi. 10.2165/11535640-000000000-00000

By:

Kaier, Klaus;
Frank, Uwe

Publication type:

Article

A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States.

Published in:

PharmacoEconomics, 2010, v. 28, n. 12, p. 1109, doi. 10.2165/11537300-000000000-00000

By:

Mavranezouli, Ifigeneia

Publication type:

Article

Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices.

Published in:

PharmacoEconomics, 2010, v. 28, n. 12, p. 1097, doi. 10.2165/11537400-000000000-00000

By:

Lizheng Shi;
Jinan Liu;
Koleva, Yordanka;
Fonseca, Vivian;
Kalsekar, Anupama;
Pawaskar, Manjiri

Publication type:

Article

The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions.

Published in:

PharmacoEconomics, 2010, v. 28, n. 12, p. 1079, doi. 10.2165/11537760-000000000-00000

By:

Andrea Manca;
Sculpher, Mark J.;
Goeree, Ron

Publication type:

Article

The Economics of a 'Liberated' NHS.

Published in:

2010

By:

Devlin, Nancy J.

Publication type:

Opinion

Is There a Role for Pharmacoeconomics in Developing Countries?

Published in:

PharmacoEconomics, 2010, v. 28, n. 12, p. 1069, doi. 10.2165/11584890-000000000-00000

By:

Babar, Zaheer-Ud-Din;
Scahill, Shane

Publication type:

Article

New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunition.

Published in:

2010

By:

Antoñanzas F;
Gómez P;
Antoñanzas, Fernando;
Gómez, Pedro

Publication type:

Editorial

Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses: A Decision Tree Model.

Published in:

PharmacoEconomics, 2010, v. 28, n. 11, p. 1055, doi. 10.2165/11538670-000000000-00000

By:

Wilson, Edward C.F.

Publication type:

Article

Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy.

Published in:

PharmacoEconomics, 2010, v. 28, n. 11, p. 1041, doi. 10.2165/11538600-000000000-00000

By:

Eandi, Mario;
Pradelli, Lorenzo;
Iannazzo, Sergio;
Chiroli, Silvia;
Pontoriero, Giuseppe

Publication type:

Article

Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV.

Published in:

PharmacoEconomics, 2010, v. 28, n. 11, p. 1025, doi. 10.2165/11535540-000000000-00000

By:

Kauf, Teresa L.;
Farkouh, Raymond A.;
Earnshaw, Stephanie R.;
Watson, Maria E.;
Maroudas, Penny;
Chambers, Mike G.

Publication type:

Article

Economic Implications of Sleep Disorders.

Published in:

PharmacoEconomics, 2010, v. 28, n. 11, p. 1015, doi. 10.2165/11537390-000000000-00000

By:

Skaer, Tracy L.;
Sclar, David A.

Publication type:

Article

Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review.

Published in:

PharmacoEconomics, 2010, v. 28, n. 11, p. 1001, doi. 10.2165/11537410-000000000-00000

By:

Wong, William B.;
Carlson, Josh J.;
Thariani, Rahber;
Veenstra, David L.

Publication type:

Article

Methods of Model Calibration: Observations from a Mathematical Model of Cervical Cancer.

Published in:

PharmacoEconomics, 2010, v. 28, n. 11, p. 995, doi. 10.2165/11538660-000000000-00000

By:

Taylor, Douglas C.A.;
Pawar, Vivek;
Kruzikas, Denise;
Gilmore, Kristen E.;
Pandya, Ankur;
Iskandar, Rowan;
Weinstein1, Milton C.

Publication type:

Article

An Analysis of NICE's 'Restricted' (or 'Optimized') Decisions.

Published in:

PharmacoEconomics, 2010, v. 28, n. 11, p. 987, doi. 10.2165/11536970-000000000-00000

By:

O'Neill, Phill;
Devlin, Nancy J.

Publication type:

Article

Evaluation of Benefit-Risk.

Published in:

PharmacoEconomics, 2010, v. 28, n. 11, p. 981, doi. 10.2165/11537590-000000000-00000

By:

Garattini, Silvio

Publication type:

Article

Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.

Published in:

2010

By:

Signorovitch JE;
Wu EQ;
Yu AP;
Gerrits CM;
Kantor E;
Bao Y;
Gupta SR;
Mulani PM;
Signorovitch, James E;
Wu, Eric Q;
Yu, Andrew P;
Gerrits, Charles M;
Kantor, Evan;
Bao, Yanjun;
Gupta, Shiraz R;
Mulani, Parvez M

Publication type:

journal article

New Prescription for the Spanish Drug Sector: Fighting against Public Deficit without Wasting Ammunition.

Published in:

2010

By:

Antoñanzas, Fernando;
Gómez, Pedro

Publication type:

Editorial

Comparative effectiveness, personalized medicine and innovation: the path forward.

Published in:

2010

By:

Thomas A;
Phillips A;
Donnelly R;
Piech CT;
Thomas, Adrian;
Phillips, Audrey;
Donnelly, Robert;
Piech, Catherine Tak

Publication type:

journal article

Regulatory benefit-risk assessment and comparative effectiveness research: strangers, bedfellows or strange bedfellows?

Published in:

2010

By:

Garrison LP;
Garrison, Louis P

Publication type:

journal article

The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research.

Published in:

2010

By:

Meltzer D;
Basu A;
Conti R;
Meltzer, David;
Basu, Anirban;
Conti, Rena

Publication type:

journal article

Guiding comparative effectiveness research--a US perspective: an interview between Howard Birnbaum (of Analysis Group, Inc., and Guest Co-Editor of this Special Issue) and Jean R. Slutsky (Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality). Interview by Howard Birnbaum.

Published in:

2010

By:

Slutsky JR;
Slutsky, Jean R

Publication type:

Interview

International comparison of comparative effectiveness research in five jurisdictions: insights for the US.

Published in:

2010

By:

Levy AR;
Mitton C;
Johnston KM;
Harrigan B;
Briggs AH;
Levy, Adrian R;
Mitton, Craig;
Johnston, Karissa M;
Harrigan, Brian;
Briggs, Andrew H

Publication type:

journal article

Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and future.

Published in:

2010

By:

Chalkidou K;
Walley T;
Chalkidou, Kalipso;
Walley, Tom

Publication type:

journal article

Perspectives on comparative effectiveness research: views from diverse constituencies.

Published in:

2010

By:

Nellesen D;
Birnbaum HG;
Greenberg PE;
Nellesen, Dave;
Birnbaum, Howard G;
Greenberg, Paul E

Publication type:

Editorial

Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 969, doi. 10.2165/11536160-000000000-00000

By:

Mullins, C. Daniel;
Whicher, Danielle;
Reese, Emily S.;
Tunis, Sean

Publication type:

Article

No Head-to-Head Trial? Simulate the Missing Arms.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 957, doi. 10.2165/11537420-000000000-00000

By:

Caro, J. Jaime;
Ishak, K. Jack

Publication type:

Article

There's a Reason They Call Them Dummy Variables.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 947, doi. 10.2165/11537750-000000000-00000

By:

Crown, William H.

Publication type:

Article

Comparative Effectiveness Without Head-to-Head Trials.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 935, doi. 10.2165/11538370-000000000-00000

By:

Signorovitch, James E.;
Wu, Eric Q.;
Yu, Andrew P.;
Gerrits, Charles M.;
Kantor, Evan;
Bao, Yanjun;
Gupta, Shiraz R.;
Mulani, Parvez M.

Publication type:

Article

Managed Care Pharmacy Sees Potential of Comparative Effectiveness Research to Improve Patient Care and Lower Costs.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 931, doi. 10.2165/11535610-000000000-00000

By:

Cahill, Judith;
Learner, Neal

Publication type:

Article

Comparative Effectiveness, Personalized Medicine and Innovation.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 923, doi. 10.2165/11539030-000000000-0000010.2165/11537370-000000000-00000

By:

Thomas, Adrian;
Phillips, Audrey;
Donnelly, Robert;
Tak Piech, Catherine

Publication type:

Article

Comparative Effectiveness Research.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 915, doi. 10.2165/11535400-000000000-00000

By:

Berger, Marc L.;
Grainger, David

Publication type:

Article

Comparative Effectiveness Research and Personalized Medicine.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 905, doi. 10.2165/11535830-000000000-00000

By:

Epstein, Robert S.;
Teagarden, J. Russell

Publication type:

Article

Comparative Effectiveness Research and the Psychology of Medical Practice.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 899, doi. 10.2165/11535620-000000000-00000

By:

Kassirer, Jerome P.;
Wong, John B.

Publication type:

Article

Perspective and Desire in Comparative Effectiveness Research.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 889, doi. 10.2165/11535270-000000000-00000

By:

Culyer, Anthony J.

Publication type:

Article

Comparative Effectiveness Regulations and Pharmaceutical Innovation.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 877, doi. 10.2165/11537570-000000000-00000

By:

Vernon, John A.;
Golec, Joseph H.;
Stevens, J. Stedman

Publication type:

Article